Fibroblast Growth Factor 23 in Multiple Myeloma Patients with Renal Impairment

被引：0
作者：
Ibrahim, Nahed Moawad [1 ]
El Afifi, Amal Mostafa [1 ]
Abdelallim, Nada Shawky Rizk [1 ]
Abdullah, Nour El Hoda Hussein [1 ]
机构：
[1] Ain Shams Univ, Clin Hematol & Bone Marrow Transplantat Unit, Fac Med, Cairo, Egypt
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2021年 / 21卷
关键词：
MM; fibroblast growth factor 23; newly diagnosed multiple myeloma; renal impairment;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MM-299
引用
收藏
页码：S434 / S434
页数：1
相关论文
共 50 条
  • [41] A pharmacokinetics and safety phase 1/1b study of oral ixazomib in patients with multiple myeloma and severe renal impairment or end-stage renal disease requiring haemodialysis
    Gupta, Neeraj
    Hanley, Michael J.
    Harvey, R. Donald
    Badros, Ashraf
    Lipe, Brea
    Kukreti, Vishal
    Berdeja, Jesus
    Yang, Huyuan
    Hui, Ai-Min
    Qian, Mark
    Zhang, Xiaoquan
    Venkatakrishnan, Karthik
    Chari, Ajai
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 174 (05) : 748 - 759
  • [42] Clinical features and treatment outcome of elderly multiple myeloma patients with impaired renal function
    Chen, Jin
    Liu, Hui
    Li, Lijuan
    Liu, Zhaoyun
    Song, Jia
    Wang, Guojin
    Wang, Huaquan
    Ruan, Erbao
    Ding, Kai
    Shao, Zonghong
    Fu, Rong
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2019, 33 (05)
  • [43] Reversibility of renal failure in newly diagnosed patients with multiple myeloma and the role of novel agents
    Roussou, Maria
    Kastritis, Efstathios
    Christoulas, Dimitrios
    Migkou, Magdalini
    Gavriatopoulou, Maria
    Grapsa, Irini
    Psimenou, Erasmia
    Gika, Dimitra
    Terpos, Evangelos
    Dimopoulos, Meletios A.
    LEUKEMIA RESEARCH, 2010, 34 (10) : 1395 - 1397
  • [44] Serum free light chain levels and renal function at diagnosis in patients with multiple myeloma
    Yaday, Punit
    Cockwell, Paul
    Cook, Mark
    Pinney, Jennifer
    Giles, Hannah
    Aung, Yu Sandar
    Cairns, David
    Owen, Roger G.
    Davies, Faith E.
    Jackson, Graham H.
    Child, J. Anthony
    Morgan, Gareth J.
    Drayson, Mark T.
    BMC NEPHROLOGY, 2018, 19
  • [45] Albumin-to-Globulin Ratio Combined with Neutrophil-to-Lymphocyte Ratio as a Prognostic Predictor in Multiple Myeloma with Renal Impairment
    Zhang, Yingzi
    Yao, Xiajuan
    Zhang, Yaoquan
    Chen, Zhuyun
    Qin, Zhongke
    Cai, Ying
    Xia, Wenkai
    Hu, Hong
    BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY, 2024, 14
  • [46] Induction Therapy with Novel Agents and Autologous Stem Cell Transplant Overcomes the Adverse Impact of Renal Impairment in Multiple Myeloma
    Lalit Kumar
    Santosh Kumar Chellapuram
    Ramavat Dev
    Ankur Varshneya
    Satyajit Pawar
    Aparna Sharma
    Anjali Mookerjee
    Ranjit Kumar Sahoo
    Prabhat Singh Malik
    Atul Sharma
    Ritu Gupta
    Omdutta Sharma
    Ahitagni Biswas
    Rakesh Kumar
    Sanjay Thulkar
    Sauumyaranjan Mallick
    Clinical Hematology International, 2019, 1 (4) : 205 - 219
  • [47] Bortezomib overcomes the negative prognostic impact of renal impairment in a newly diagnosed elderly patient with multiple myeloma: A case report
    Wu, Tao
    Zhou, Jinmao
    Wang, Cunbang
    Wang, Binbin
    Zhang, Shuting
    Bai, Hai
    ONCOLOGY LETTERS, 2017, 14 (06) : 7318 - 7322
  • [48] Serum free light chain levels and renal function at diagnosis in patients with multiple myeloma
    Punit Yadav
    Paul Cockwell
    Mark Cook
    Jennifer Pinney
    Hannah Giles
    Yu Sandar Aung
    David Cairns
    Roger G. Owen
    Faith E. Davies
    Graham H. Jackson
    J. Anthony Child
    Gareth J. Morgan
    Mark T. Drayson
    BMC Nephrology, 19
  • [49] Daratumumab, Bortezomib, and Dexamethasone for Treatment of Patients with Relapsed or Refractory Multiple Myeloma and Severe Renal Impairment: Results from the Phase 2 GMMG-DANTE Trial
    Leypoldt, Lisa B.
    Gavriatopoulou, Maria
    Besemer, Britta
    Salwender, Hans
    Raab, Marc S.
    Nogai, Axel
    Khandanpour, Cyrus
    Runde, Volker
    Jauch, Anna
    Zago, Manola
    Martus, Peter
    Goldschmidt, Hartmut
    Bokemeyer, Carsten
    Dimopoulos, Meletios A.
    Weisel, Katja C.
    CANCERS, 2023, 15 (18)
  • [50] Ensemble docking to difficult targets in early-stage drug discovery: Methodology and application to fibroblast growth factor 23
    Velazquez, Hector A.
    Riccardi, Demian
    Xiao, Zhousheng
    Quarles, Leigh Darryl
    Yates, Charless Ryan
    Baudry, Jerome
    Smith, Jeremy C.
    CHEMICAL BIOLOGY & DRUG DESIGN, 2018, 91 (02) : 491 - 504
12345